reduce basal insulin when starting glp-1 receptor agonist GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome reduce basal insulin when starting

These modified GLP-1 analogues retain the beneficial properties while allowing practical therapeutic application

One finding from cystoscopy that can help in making an IC diagnosis is the presence of reddened patches or lesions called Hunners ulcers, which can stiffen tissue and cause reduced bladder capacity

For patients on established B12 injection therapy, monitoring is based primarily on clinical response and haematological parameters rather than routine serum B12 measurements, which may remain very high without indicating harm or overtreatment

In the absence of complications, patients are afebrile, with a biliary-type pain (occasionally asymptomatic), nausea, and vomiting